Inhibition of HIV-1 in cell culture by synthetic humate analogues derived from hydroquinone: mechanism of inhibition., PMID:8610466
The entire SU subunit is required for the incorporation of the HIV-1 envelope glycoprotein complex into virions., PMID:9311566
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations., PMID:9126269
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells., PMID:9238030
Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine., PMID:9814959
A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes., PMID:11545619
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus., PMID:11991960
Expression of the human CD4 receptor is sufficient for the transduction of murine T-cells with MLV/HIV pseudotyped vectors., PMID:12191776
Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity., PMID:14592772
Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding., PMID:27604319
Probing the HIV gp120 envelope glycoprotein conformation by NMR. PMID: 21592971
Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments. PMID: 22117536
Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5. PMID: 21284403
Role of the HIV gp120 conserved domain 1 in processing and viral entry. PMID: 18815131
The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120. PMID: 25403811
Role of the HIV gp120 conserved domain 5 in processing and viral entry. PMID: 18597484
Enhanced dynamics of HIV gp120 glycoprotein by small molecule binding. PMID: 21488663
Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells. PMID: 18406166
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. PMID: 29463753
HIV N-linked glycosylation site analyzer and its further usage in anchored alignment. PMID: 23748959
HIV gp120 and morphine alter mu opiate receptor expression in human vascular endothelium. PMID: 11445868
Receptor binding domain based HIV vaccines. PMID: 25667925
Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120. PMID: 22674993
Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. PMID: 16227233
Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: implications for HIV-associated neurodegeneration. PMID: 22575597
The HIV-1 gp120 major variable regions modulate cold inactivation. PMID: 23345516
Targeting of HIV gp120 by oligonucleotide-photosensitizer conjugates. Light-induced damages. PMID: 10622747
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120. PMID: 12665517
Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5. PMID: 25797607
Structural plasticity and conformational transitions of HIV envelope glycoprotein gp120. PMID: 23300605
A synthetic conformational epitope from the C4 domain of HIV Gp120 that binds CD4. PMID: 8663408
Molecular architecture of native HIV-1 gp120 trimers. PMID: 18668044
Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120. PMID: 22230366
HIV-gp120 can block CD4-class II MHC-mediated adhesion. PMID: 1967269
HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug. PMID: 22615295
Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting. PMID: 28102671
Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop. PMID: 24048002
A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4. PMID: 28429756
An antibody-recruiting small molecule that targets HIV gp120. PMID: 19839582
Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor. PMID: 34372601
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors. PMID: 23487463
The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop. PMID: 24303005
Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120. PMID: 21600706
Virion attachment and entry: HIV gp120 Env biotinylation, gp120 Env, or integrin ligand-binding assay. PMID: 24158809
Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564. PMID: 15207637
HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. PMID: 19698075
Opening dynamics of HIV-1 gp120 upon receptor binding is dictated by a key hydrophobic core. PMID: 31764922
HIV unbound. PMID: 15812519
gp120 sequences from HIV type 1 subtype C early seroconverters in India. PMID: 15320993
The antigenic structure of the HIV gp120 envelope glycoprotein. PMID: 9641684
Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamus. PMID: 24120859
Comparative glycoprofiling of HIV gp120 immunogens by capillary electrophoresis and MALDI mass spectrometry. PMID: 25809283
Tubular cell HIV-1 gp120 expression induces caspase 8 activation and apoptosis. PMID: 19462280
Allosteric induction of the CD4-bound conformation of HIV-1 Gp120. PMID: 24304511
HIV-1 gp120 envelope protein modulates proliferation of human glomerular epithelial cells. PMID: 10581001
HIV gp120 receptors on human dendritic cells. PMID: 11588046
Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. PMID: 25652249
Probing of CD4 binding pocket of HIV-1 gp120 glycoprotein using unnatural phenylalanine analogues. PMID: 25453804
Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. PMID: 22451932
Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region. PMID: 29346393
V3: HIV's switch-hitter. PMID: 15725757
Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling. PMID: 27165479
Substance abuse and HIV-gp120: are opiates protective? PMID: 10202562
CD4-binding obstacles in conformational transitions and allosteric communications of HIV gp120. PMID: 32061646
HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism. PMID: 23011758
High level stable expression of recombinant HIV gp120 in glutamine synthetase gene deficient HEK293T cells. PMID: 33529763
Molecular mechanism of HIV-1 gp120 mutations that reduce CD4 binding affinity. PMID: 23297802
NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation. PMID: 24819826
Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120. PMID: 31792886
Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120. PMID: 34921512
HIV vaccine candidates. PMID: 15645007
HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands. PMID: 25712564
HIV gp120 is an aberrant chemoattractant for blood resting CD4 T cells. PMID: 22954308
Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice. PMID: 23252824
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection. PMID: 33288704
The role of the V3 loop of gp120 in HIV infection. PMID: 1845049
Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals. PMID: 32191306
Interactions of HIV gp120 with the CD4 molecule on lymphocytes and in the nervous system. PMID: 2198840
HIV gp120 interactions with coreceptors: insights from studies with CCR5-based peptides. PMID: 17933721
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements. PMID: 34246921
Mechanisms of Blood-Retinal Barrier Disruption by HIV-1. PMID: 30873925
HIV-1 proteins gp120 and tat induce the epithelial-mesenchymal transition in oral and genital mucosal epithelial cells. PMID: 31869348
HIV gp120 induced gene expression signatures in vaginal epithelial cells. PMID: 23867815
Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine. PMID: 18220757
Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy. PMID: 23278399
Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury. PMID: 22124968
Immune responses to HIV Gp120 that facilitate viral escape. PMID: 17266556
HIV gp120: double lock strategy foils host defences. PMID: 9739096
HIV-1 gp120: a novel viral B cell superantigen. PMID: 9186784
HIV-1 gp120 and immune network. PMID: 15370273
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. PMID: 9641677
The GP120 molecule of HIV-1 and its interaction with T cells. PMID: 20088758
For research use only. Not for human or drug use.
